The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

作者：黄莺美国Moderna公司的专利官司持续不断。一周前，2024年10月12日，葛兰素史克公司（GSK）向美国特拉华州地方法院起诉Moderna，指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...

In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.

作者：黄莺俗话说人红是非多。在新冠疫情期间，凭借mRNA疫苗大获成功的Moderna公司，从年营收只有几千万美元的公司，一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年，Moderna与美国国立卫生研究院的mRNA ...

The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.18%. Elsewhere, ...

TD Cowen维持对Moderna股票(NASDAQ: MRNA)的"持有"评级，目标价保持在60.00美元不变。 该公司在生物科技板块第三季度财报预览前发布了这一更新，并对Moderna的财务模型进行了调整。

Moderna ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

格隆汇10月17日｜美国西北大学在特拉华州联邦法院对Moderna提起了一项新的专利诉讼。该诉讼称，Moderna在新冠疫苗Spikevax中未经许可使用西北大学开发的脂质纳米颗粒(LNP)技术，将脆弱的mRNA运输到人体内。Moderna的一位发言 ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

周三，美国西北大学 (Northwestern University)在特拉华州联邦法院对Moderna (MRNA.US)提起了一项新的专利诉讼，指控该公司滥用该校的创新成果来开发其重磅的新冠疫苗Spikevax。